Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 5589Session 2025-2026

Provides public access to epinephrine auto-injector devices at schools

S5589

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content

New York State Assembly

Speaker Carl E. Heastie

  • Assembly Members
  • Legislative Info
  • Public Hearings
  • Speaker's Press
  • Assembly Reports
  • Committees & More
  • Bill Search Home
  • Laws
  • Legislative Calendar
  • Public Hearing Schedule
  • Assembly Calendars
  • Assembly Committee Agenda
Javascript must be enabled to properly view this page. Bill No.:  
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee&nbspVotes 
  •  
  •  Floor&nbspVotes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber&nbspVideo/Transcript 

S05589 Summary:

BILL NOS05589
 
SAME ASSAME AS A02648
 
SPONSORLIU
 
COSPNSRBROUK, CLEARE, GALLIVAN, OBERACKER, RIVERA
 
MLTSPNSR
 
Amd ?921-a, Ed L; amd ?3000-c, Pub Health L
 
Provides public access to epinephrine auto-injector devices at schools; establishes public access epinephrine auto-injector device providers.
Go to top

S05589 Text:

STATE OF NEW YORK ________________________________________________________________________ 5589 2025-2026 Regular Sessions IN SENATE February 25, 2025 ___________ Introduced by Sen. LIU -- read twice and ordered printed, and when printed to be committed to the Committee on Education AN ACT to amend the education law and the public health law, in relation to providing public access to epinephrine auto-injector devices at schools The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 921-a of the education law is amended by adding a 2 new subdivision 4 to read as follows: 3 4. School districts, boards of cooperative educational services, coun- 4 ty vocational education and extension boards, charter schools, and non- 5 public elementary and secondary schools in this state shall be deemed 6 "public access epinephrine auto-injector device providers" as defined in 7 paragraph (d) of subdivision one of section three thousand-c of the 8 public health law and shall be subject to the requirements and limita- 9 tions of such section. 10 § 2. Subdivision 1 of section 3000-c of the public health law is 11 amended by adding a new paragraph (d) to read as follows: 12 (d) "Public access epinephrine auto-injector device provider" means a 13 person, firm, organization or other entity possessing or operating an 14 epinephrine auto-injector device pursuant to this section. 15 § 3. Subdivision 2 of section 3000-c of the public health law is 16 amended by adding a new paragraph (g) to read as follows: 17 (g) A public access epinephrine auto-injector device provider shall: 18 (i) cause an epinephrine auto-injector device to be maintained and 19 tested according to applicable standards of the manufacturer and any 20 appropriate government agency. 21 (ii) notify the regional council of the existence, location and type 22 of any epinephrine auto-injector device it possesses. 23 (iii) post a sign or notice at the main entrance to the facility or 24 building in which the epinephrine auto-injector device is stored, indi- EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05464-01-5 S. 5589 2 1 cating the location where any such epinephrine auto-injector device is 2 stored or maintained in such building or facility on a regular basis. 3 § 4. This act shall take effect on the ninetieth day after it shall 4 have become a law. Go to top <link href="/styles/noscript_styles.css" rel="stylesheet"/> Sitemap Request Information Directions and Maps

Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.